These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 26066739)

  • 1. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.
    Ahmad MZ; Alkahtani SA; Akhter S; Ahmad FJ; Ahmad J; Akhtar MS; Mohsin N; Abdel-Wahab BA
    J Drug Target; 2016; 24(4):273-93. PubMed ID: 26066739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in nanotechnology-based delivery systems for curcumin.
    Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
    Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin.
    Chaurasia S; Patel RR; Chaubey P; Kumar N; Khan G; Mishra B
    Carbohydr Polym; 2015 Oct; 130():9-17. PubMed ID: 26076595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
    Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
    Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
    Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
    Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
    Liu J; Chen S; Lv L; Song L; Guo S; Huang S
    Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis.
    Liu L; Sun L; Wu Q; Guo W; Li L; Chen Y; Li Y; Gong C; Qian Z; Wei Y
    Int J Pharm; 2013 Feb; 443(1-2):175-82. PubMed ID: 23287774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Targeted Curcumin Delivery by Folate-Modified MPEG-PCL Self-Assembly Micelles for Colorectal Cancer Therapy.
    Hu Y; He Y; Ji J; Zheng S; Cheng Y
    Int J Nanomedicine; 2020; 15():1239-1252. PubMed ID: 32110020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of curcumin nanoemulsions on prostate cancer.
    Guan YB; Zhou SY; Zhang YQ; Wang JL; Tian YD; Jia YY; Sun YJ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):371-378. PubMed ID: 28585133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
    Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
    Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
    Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
    Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
    J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel delivery using carrier made from curcumin derivative: synergism between carrier and the loaded drug for effective cancer treatment.
    Amornwachirabodee K; Chiablaem K; Wacharasindhu S; Lirdprapamongkol K; Svasti J; Vchirawongkwin V; Wanichwecharungruang SP
    J Pharm Sci; 2012 Oct; 101(10):3779-86. PubMed ID: 22806358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth.
    Naksuriya O; Shi Y; van Nostrum CF; Anuchapreeda S; Hennink WE; Okonogi S
    Eur J Pharm Biopharm; 2015 Aug; 94():501-12. PubMed ID: 26134273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo.
    Zhang J; Liang YC; Lin X; Zhu X; Yan L; Li S; Yang X; Zhu G; Rogach AL; Yu PK; Shi P; Tu LC; Chang CC; Zhang X; Chen X; Zhang W; Lee CS
    ACS Nano; 2015 Oct; 9(10):9741-56. PubMed ID: 26390118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and biological properties of NanoCUR formulation and its effect on major human cytochrome P450 enzymes.
    Shamsi S; Chen Y; Lim LY
    Int J Pharm; 2015 Nov; 495(1):194-203. PubMed ID: 26319630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.